Dr Boyle is an Academic Clinical Lecturer, and specialty trainee, in Intensive Care Medicine. He has held clinical academic appointments throughout much of his clinical training in Northern Ireland and Australia.

Andrew's PhD evaluated mechanisms of, and risk factors for, lung injury in the critically ill, during which he undertook a range of laboratory and clinical studies that aimed to improve understanding of lung injury in patients receiving mechanical ventilation in the intensive care unit.

Andrew's current research programme aims to improve outcomes for critically ill patients. It is recognised that critically ill patients who have syndromes such as severe respiratory failure or sepsis, can be subdivided into more specific subgroups. These subgroups may be characterised by differences in their body's response to critical illness. Andrew's research seeks to first identify new traits that define subgroups of critically ill patients, before second, studying whether these traits can be used to identify subgroups of patients who benefit from a specific treatment within clinical trials. He aims to do this using a biological and data-driven approach to his research programme and the clinical trials he leads. 

The primary focus of his current research is on evaluating the role of anakinra as a treatment for ARDS, as part of an NIHR EME-Advanced Fellowship.

Andrew is open to collaboration and welcomes enquiries from individuals interested in undertaking lab, clinical and data-driven research, and is keen to help individuals develop their own research ideas.

• Acute respiratory distress syndrome
• Precision medicine
• Clinical trials, including data-enabled trials
• Ventilator-induced lung injury
• Sepsis